DNAJC2 and neuroblastoma: We believe that this study extends our knowledge about the regulation of lipid metabolic reprogramming and mitochondrial activity by circRNA-coding protein, and reveals p113/ZRF1/BRD4 axis as a potential therapeutic target for NB progression.